Exelixis, Inc.
NASDAQExelixis heads into the back half of August with short sellers retreating and the Street divided on whether the recent pullback has created a buying opportunity — or simply confirmed the stock's ceiling. The positioning story is the more interesting one right now. Short interest has fallen nearly 5% on the week to 10.6% of free float, unwinding a buildup that peaked around 30…
EXEL put-call ratio spikes to 1.33, a 4.1 standard deviations above the 20-day mean of 0.65, signaling extreme options hedging demand as short interest holds firm at 11.3% of float.
Snapshot as of 20 Sept 2026
Exelixis heads into the back half of August with short sellers retreating and the Street divided on whether the recent pullback has created a buying opportunity — or simply confirmed the stock's ceiling. The…
Exelixis heads into its July 28 earnings with a notably more defensive options skew than at any point in recent months — even as short sellers add modestly to positions and the stock trades near analyst targets. The…
Exelixis enters the post-earnings stretch with a clean beat behind it, a $750 million buyback in hand, and a fresh pipeline catalyst — yet short sellers have quietly added to their positions all month, setting up a…
EXEL heads into its May 5 Q1 results with short sellers at their most aggressive in months — and the stock down 4.6% on the week despite an otherwise healthy April. The short interest story is the week's defining…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for EXEL — free to start on ORTEX.
Sign up for free →Open EXEL on ORTEX